Clinical trial

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

NCT04541381

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2022-02-07

PhaseNA

Study timeline

Study start (actual)2022-02-07Date precision: day

Registry last updated2026-05-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Gastrointestinal Cancerunresolved

Head and Neck Cancerunresolved

Dihydropyrimidine Dehydrogenase Deficiencyunresolved

UGT1A1 Gene Mutationunresolved

Breast Cancerunresolved

Interventions

Availability of clinical decision support based on pharmacogenomic results.OTHER

Sponsors & collaborators

University of Chicagolead sponsor

National Human Genome Research Institute (NHGRI)collaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04541381 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.